HCC patients with a higher expression of GPx4 significantly exhibited more a favorable prognosis than those with a lower expression of GPx4 because GPx4 inhibited the development of HCC by way of the regulation of angiogenesis and the modulation of immune-mediated cells [162]. The gene discussed is GPX4; the disease is hepatocellular carcinoma.